Melinda Conrad

Melinda Blanton Conrad currently works at Stockland, as Independent Non-Executive Director from 2018, Stockland Corp.
Ltd., as Non-Executive Director from 2018, Virgin Australia Holdings Ltd., as Independent Non-Executive Director from 2025, PentenAmio Pty Ltd., as Director, The Centre for Independent Studies, as Non-Executive Director, Stockland Trust Management Ltd., as Non-Executive Director from 2018, New South Wales Department of Health, as Director, The Clinical Excellence Commission, as Non-Executive Director, Agency for Clinical Innovation, as Non-Executive Director from 2012, Penten Pty Ltd., as Director from 2021, Australian Institute of Co. Directors, as Member, Five V Capital Pty Ltd, as Advisory Board Member from 2018, and Chief Executive Women, Inc., as Member.
Ms. Conrad also formerly worked at David Jones Pty Ltd., as Independent Non-Executive Director from 2013 to 2014, Dollarama Australia Pty Ltd., as Independent Non-Executive Director from 2011 to 2017, ARN Media Ltd., as Independent Non-Executive Director from 2012 to 2013, OzForex Ltd., as Non-Executive Director from 2013 to 2018, The Garvan Institute of Medical Research, as Director, Ampol Ltd., as Independent Non-Executive Director from 2017 to 2026, Australian Brandenburg Orchestra, as Director, OFX Group Ltd., as Independent Non-Executive Director from 2013 to 2018, Garvan Research Foundation, as Non-Executive Director from 2003 to 2015, The George Institute for Global Health, as Non-Executive Director, and ASX Ltd., as Independent Non-Executive Director from 2016 to 2025.
Ms. Conrad received her undergraduate degree in 1991 from Wellesley College and Masters Business Admin degree in 1997 from Harvard Business School.